VivoSim Labs, INC. (VIVS): who owns it and who trades it
As of Oct 30, 2026, VIVS insiders reported 1 open-market sale worth $7.3K and 1 purchase worth $2.8K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was David Gobel (Director), with $7.3K.
Latest filing Oct 30, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
In the last 12 months, VIVS insiders reported $2.8K of open-market purchases and $7.3K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Tony Serge Lialin | Chief Commercial Officer | Purchase | 10,000 | $0.28 | $2.8K | Form 4 |
| Nov 17, 2025 | David Gobel | Director | Sale | 3,266 | $2.24 | $7.3K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| David Gobel | Director | – | $7.3K | Nov 17, 2025 |
| Tony Serge Lialin | Chief Commercial Officer | $2.8K | – | Aug 31, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
VIVS short interest
High short interest. 18.6% of VIVS shares are sold short: about 1 share in 5. Over the last 12 reports the number of shares short went up 1513%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 649,569 VIVS shares were sold short, 18.6% of the shares outstanding, up 8.5% from the report before. At the average daily volume of 1.14M shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 649,569 | 18.59% | +9% | 1.14M | 1.0 |
| Oct 15, 2026 | 598,424 | 17.13% | -15% | 813,078 | 1.0 |
| Sep 30, 2026 | 707,866 | 20.26% | +25% | 1.26M | 1.0 |
| Sep 15, 2026 | 564,680 | 16.16% | -20% | 519,015 | 1.1 |
| Aug 31, 2026 | 706,772 | 20.23% | -6% | 837,163 | 1.0 |
| Aug 14, 2026 | 751,416 | 21.51% | +32% | 12.15M | 1.0 |
| Jul 31, 2026 | 570,467 | 16.33% | +1071% | 8.48M | 1.0 |
| Jul 15, 2026 | 48,730 | 1.39% | -57% | 11.40M | 1.0 |
| Jun 30, 2026 | 113,911 | 4.37% | +470% | 157,314 | 1.0 |
| Jun 15, 2026 | 19,972 | 0.77% | -40% | 58,969 | 1.0 |
| May 29, 2026 | 33,344 | 1.28% | -17% | 51,620 | 1.0 |
| May 15, 2026 | 40,282 | 1.54% | -24% | 34,290 | 1.2 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
VivoSim Labs company events
VivoSim Labs filed 9 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership, listing). The latest was on Oct 16, 2026.
- Oct 16, 2026AgreementOrganovo, Inc., a wholly-owned subsidiary of VivoSim Labs, Inc., entered into a Second Amendment to Amended and Restated Lease with San Diego Inspire 2, LLC. Filing
- Oct 6, 2026LeadershipVivoSim Labs, Inc. held its 2026 Annual Meeting of Stockholders. Filing
- Aug 21, 2026ListingVivoSim Labs, Inc., a Delaware corporation, received a written notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company no longer met the… Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- Jul 30, 2026AnnouncementThe Company announced that the Annual Meeting will be held on September 30, 2026 and that the Record Date will be August 13, 2026. Filing
- Jul 24, 2026ListingVivoSim Labs, Inc., a Delaware corporation, received a written notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC indicating that, since the Company’s Annual Report on Form 10-K for the period ended March 31, 2026, reported stockholders’ equity of $(1,099,000), and as of… Filing
- Jul 17, 2026AgreementVivoSim Labs, Inc. entered into a Securities Purchase Agreement with an accredited institutional investor, pursuant to which, among other things, the Company agreed to issue and sell to the Purchaser, in a private placement transaction, (i) pre-funded warrants to purchase up to an aggregate of… Filing
- Apr 3, 2026AgreementVivoSim Labs, Inc. priced a best efforts public offering of up to 3,508,772 shares of its common stock, par value $0.001 per share, or up to 3,508,772 pre-funded warrants to purchase up to an aggregate of 3,508,772 shares of Common Stock in lieu thereof, together with an aggregate of up to… Filing
- Dec 18, 2025VoteReported shareholder vote results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
VivoSim Labs financials
Questions about VivoSim Labs, INC. (VIVS) stock
Are VIVS insiders buying or selling?
In the last 12 months, VIVS insiders reported 1 open-market purchase worth $2.8K and 1 sale worth $7.3K. The latest trade was on Aug 31, 2026. See every trade.
What is the short interest in VIVS?
As of Oct 30, 2026, 649,569 VIVS shares were sold short, 18.6% of the shares outstanding, up 8.5% from the report before. At the average daily volume of 1.14M shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Executive pay
VivoSim Labs's chief executive was paid a total of $866K for the year ended Mar 31, 2026, down 26% from $1.2M the year before. In the last 12 months, VivoSim Labs's executives and directors bought $2.8K of stock on the open market and sold $7.3K.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.